Columbia scientists have created new decoy drugs that can intercept the deceptive growth signals that cancer cells send out.
A study of the genomes of patients with a particularly aggressive form of non-Hodgkin’s lymphoma shows that many cases are driven by alterations in the JAK/STAT3 cell signaling pathway.
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
Al final de los 1800, un cirujano…
At a special event at Columbia, oncologists and scientists will discuss how new research is changing the way cancer is being treated.
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.